Skip to main content
. 2022 Jul 20;22:232. doi: 10.1186/s12871-022-01774-7

Table 1.

Patient characteristics

No-complication group (n = 90) Complication group (n = 60) P-value
Preoperative factors
 Age (years), and median (IQR) 63.0 (51.0–72.0) 71.0 (60.3–76.0) 0.009
 Male sex, n (%) 42 (46.7) 36 (60.0) 0.134
Comorbidity, n (%)
 Hypertension 40 (44.4) 30 (50.0) 0.510
 Diabetes 22 (24.4) 10 (16.7) 0.311
 Cardiovascular disease 11 (12.2) 16 (26.7) 0.030
 Asthma 5 (5.6) 1 (1.7) 0.403
 COPD 4 (4.4) 5 (8.3) 0.485
 Liver cirrhosis 1 (1.1) 3 (5.0) 0.302
 Chronic kidney disease (eGFR ≤ 50) 9 (10.0) 12 (20.0) 0.097
 Acute infection 1 (1.1) 1 (1.7) 0.999
 Autoimmune disease 7 (7.8) 4 (6.7) 0.999
 Preoperative use of steroids 6 (6.7) 2 (3.3) 0.477
 Preoperative use of heparin 1(1.1) 1(1.7) 0.999
 ASA-PS ≥ III 17 (19.0) 23 (38.0) 0.014
 Preoperative SOFA score, median (IQR) 0 (0–0) 0 (0–1) 0.085
Intraoperative factors
 Operative time, min, median (IQR) 249.5 (159.5–379.5) 398.5 (291.3–565.0)  < 0.001
 Volume of bleeding (mL), median (IQR) 97.5 (5.0–267.5) 300 (120.0–888.8)  < 0.001
 Fluid balance (mL), median (IQR) 1432.5 (962.5–2109.5) 2710.5 (1665.0–3920.8)  < 0.001
 SAS, median (IQR) 7.0 (6.0–8.0) 6.0 (4.3–7.0)  < 0.001
Postoperative factors
 APACHE II score on admission to the ICU, median (IQR) 9 (7–11) 11 (9–14) 0.003
 Postoperative SOFA score, median (IQR) 1.0 (0–3.0) 4.0 (2.3–5.8)  < 0.001
 ICU stay (days), median (IQR) 2 (2–2) 4 (2–6)  < 0.001
 Hospital stay (days), median (IQR) 16.0 (12.8–21.3) 29.0 (20.0–37.0)  < 0.001
 Death within 28-days after surgery, n (%) 0 0  − 

APACHE II Score Acute Physiology and Chronic Health Evaluation II Score, ASA-PS American Society Anesthesiologists Physical Status Classification, COPD chronic obstructive pulmonary disease, GFR estimated glomerular filtration rate, ICU intensive care unit, IQR interquartile range, n numbers, SAS surgical Apgar score, SOFA Score Sequential Organ Failure Assessment Score